Company intelligence / Profile preview

LeMaitre Vascular

Burlington, Massachusetts, United Stateslemaitre.com ↗

Ownership: Public · LMAT
Employees: ~664
Development stage: Commercial

Overview

LeMaitre Vascular’s products—including valvulotomes, biologic patches (e.g., XenoSure), vascular grafts (e.g., artegraft), catheters for embolectomy/thrombectomy/occlusion/perfusion—are widely used in open and minimally invasive vascular surgery. Clinical data support safety and efficacy for indications such as carotid endarterectomy patching and peripheral artery bypass. Ongoing post-market surveillance confirms acceptable benefit-risk profiles[9].

Therapeutic areas: CardiovascularNephrology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Partnerships

Not specifically disclosed; company grows via acquisition rather than major pharma partnerships[1][5]

Financials

Market cap: $1.8B
Total revenue: $70.4M
Enterprise value: $1.6B

Beyond the preview

Go deeper on LeMaitre Vascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LeMaitre Vascular.

Explore the full profile